Quoin Pharmaceuticals Ltd. has announced that its Chief Financial Officer, Gordon Dunn, will be departing the company later this year following a mutual separation agreement. Dunn will remain in his current position until a successor is appointed. Further details about the separation agreement will be disclosed in future company filings.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quoin Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-066451), on July 08, 2025, and is solely responsible for the information contained therein.